Introduction
As the science-led state body on manufacturing superior quality pharmaceutical drugs, we, the State Pharmaceuticals Manufacturing Corporation (SPMC) pave the way for Sri Lankans to have access to differentiated, superior quality medicinal drugs for economically well-matched prices.
Designed and manufactured in state of the art, well-equipped laboratories and production facilities under thorough quality supervision, our pharmaceutical drugs are par with the international standards including WHO norms and standards for pharmaceuticals.
Invested on the scientific and technical excellence with a well-trained staff, recherche culture and superior Japanese technology, we pledge to deliver only the superior quality, transformational pharmaceutical drugs to both local and international markets through our pipeline.
To achieve the greatest heights the SPMC are set foot today and to raise the bar on standers constantly, smooth clockwork foining of our multiple departments including the production, quality control, R & D was vital. The dedication of each and every department and each and every employee was cogs and wheels of our success, as proven again and again.
The utmost priority and responsibility we carry is making human lives better and longer for generations now and then. And we are good at that!
A Look Back
Behind the august stride of the State Pharmaceuticals Manufacturing Corporation (SPMC), there is a significant history of forethought efforts and a diligently traversed journey.
The foundation of the SPMC was laid by the Bibile Wickramasinghe Report prepared by the late Professor Senaka Bibile and Dr S A Wickramasinghe. The report was the result of an assignment handed to Professor Senaka Bibile and Dr S A Wickramasinghe by then Prime Minister Sirimavo Bandaranayake for the task of establishing an essential drug manufacturing entity owned and operated by the government of Sri Lanka.
After the report was handed over to then Prime Minister Sirimavo Bandaranayake in 1971, the government embarked on importing essential medicinal drugs as the first phase of the plan. The second phase was manufacturing a number of selected essential drugs within the country.
In 1985, Ministry of Health prepared a proposal for the establishment of a Formulation Centre for Essential Drugs and it was accepted by the Japan International Corporation Agency (JICA). It was the culmination of the efforts and the fulfillment of the dreams of the founders of this endeavor.
Vision & Mission
Vision
To be an internationally recognized, model manufacturing and marketing organization for pharmaceuticals and health care products in South Asia.
Mission
To manufacture safe, effective and affordable medicinal drugs of superior quality up to international standards to the local and international markets.